Latest Period
Q2 2026
Security Snapshot
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) Institutional Ownership
CUSIP: 488445206
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
156
Shares (Excl. Options)
44,823,529
Price
$14.34
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- ZVRA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 44,823,529
- Total 13F value
- $641,975,385
- Portfolio coverage rank
- 0%
- Share change
- +2,916,772
- Value change
- +$55,737,269
- Number of holders
- 156
- Shares outstanding
- 59,083,593
- SEC-reported price per share
- $9.73
- Insider filing price
- $9.73
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 488445206.
- 156 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 147 to 156 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $384,581,332 to $641,975,385.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 156 institutions filings for Q2 2026.
Security key
488445206
Latest holder period
Q2 2026
13F holders
156
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
ZVRA full holder history
ZEVRA THERAPEUTICS, INC. SEC filings
ZEVRA THERAPEUTICS, INC. company facts
ZEVRA THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 488445206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ZVRA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 8.3% | +47% | $64,789,150 | +$22,456,611 | 4,915,717 | +53% | FMR LLC | 30 Jun 2026 |
| Woodline Partners LP | 8.1% | +32% | $63,076,462 | +$17,260,897 | 4,785,771 | +38% | Woodline Partners LP | 30 Jun 2026 |
| BlackRock, Inc. | 7.6% | $29,501,437 | 4,080,420 | BlackRock, Inc. | 31 Dec 2024 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $39,869,236 | 3,024,980 | Vanguard Capital Management | 30 Jun 2026 | |||
| Nantahala Capital Management, LLC | 4.4% | -20% | $16,920,608 | -$4,220,064 | 2,340,333 | -20% | Nantahala Capital Management, LLC | 31 Dec 2024 |
| Adage Capital Management, L.P. | 4% | -41% | $21,159,750 | -$13,551,750 | 2,225,000 | -39% | Adage Capital Management, L.P. | 30 Sep 2025 |
As of 30 Jun 2026, 156 institutional investors reported holding 44,823,529 shares of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA). This represents 76% of the company’s total 59,083,593 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
61%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.6% | 5,108,871 | +15% | 0% | $73,261,210 |
| FMR LLC | 8.3% | 4,915,717 | +53% | 0% | $70,491,381 |
| Woodline Partners LP | 8.1% | 4,785,771 | +39% | 0.21% | $68,627,956 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,638,910 | +6.9% | 0% | $37,841,969 |
| Nantahala Capital Management, LLC | 3% | 1,797,476 | -29% | 1.6% | $25,775,806 |
| STATE STREET CORP | 2.8% | 1,681,999 | +7.7% | 0% | $24,119,866 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 1,540,936 | +12% | 0% | $22,102,503 |
| D. E. Shaw & Co., Inc. | 2.2% | 1,306,949 | +54% | 0.01% | $18,741,649 |
| Qube Research & Technologies Ltd | 2.1% | 1,241,343 | +47% | 0.02% | $17,800,859 |
| MORGAN STANLEY | 2% | 1,203,875 | +0.97% | 0% | $17,263,567 |
| Legal & General Group Plc | 2% | 1,201,668 | +3.3% | 0% | $17,231,920 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 958,836 | +73% | 0% | $13,747,954 |
| ROYCE & ASSOCIATES LP | 1.5% | 882,658 | -11% | 0.1% | $12,657,316 |
| 683 Capital Management, LLC | 1.4% | 855,000 | -12% | 1.1% | $12,260,699 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.3% | 775,000 | 0% | 1.5% | $11,113,500 |
| Retirement Planning Co of New England, Inc. | 1.1% | 634,410 | -2.6% | 3.3% | $9,097,439 |
| Jupiter Topco LLC | 1% | 613,403 | 0% | 0% | $8,796,199 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1% | 597,162 | 0% | $8,563,303 | |
| GOLDMAN SACHS GROUP INC | 0.92% | 545,551 | -27% | 0% | $7,823,201 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.92% | 541,109 | +16% | 0% | $7,759,503 |
| NORTHERN TRUST CORP | 0.82% | 486,498 | +11% | 0% | $6,976,381 |
| Swedbank AB | 0.74% | 439,410 | 0.01% | $6,301,139 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.74% | 439,328 | -13% | 0% | $6,154,985 |
| TUDOR INVESTMENT CORP ET AL | 0.7% | 415,058 | -6.3% | 0.02% | $5,951,932 |
| Stratos Wealth Partners, LTD. | 0.69% | 408,000 | 0% | 0.06% | $5,850,720 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 44,823,529 | $641,975,385 | +$55,737,269 | $14.34 | 156 |
| 2026 Q1 | 41,315,964 | $384,581,332 | +$29,383,896 | $9.32 | 147 |
| 2025 Q4 | 38,147,770 | $341,794,447 | -$17,168,035 | $8.96 | 159 |
| 2025 Q3 | 39,900,415 | $379,438,207 | +$36,779,127 | $9.51 | 164 |
| 2025 Q2 | 36,165,830 | $318,624,169 | +$9,847,978 | $8.81 | 119 |
| 2025 Q1 | 35,351,805 | $264,779,873 | +$11,437,756 | $7.49 | 109 |
| 2024 Q4 | 33,925,967 | $282,929,757 | +$43,767,647 | $8.34 | 108 |
| 2024 Q3 | 28,925,387 | $200,746,422 | +$88,219,086 | $6.94 | 105 |
| 2024 Q2 | 16,043,055 | $78,561,424 | +$9,453,621 | $4.90 | 92 |
| 2024 Q1 | 13,910,496 | $80,679,510 | +$7,031,758 | $5.80 | 88 |
| 2023 Q4 | 12,678,435 | $83,043,757 | +$12,292,891 | $6.55 | 83 |
| 2023 Q3 | 10,800,557 | $52,059,801 | +$12,731,917 | $4.82 | 76 |
| 2023 Q2 | 8,153,478 | $41,582,121 | +$9,633,583 | $5.10 | 69 |
| 2023 Q1 | 6,153,233 | $33,836,990 | +$3,326,482 | $5.50 | 59 |
| 2022 Q4 | 5,912,306 | $27,146,724 | -$3,423,716 | $4.59 | 66 |
| 2022 Q3 | 6,683,041 | $41,695,480 | -$3,025,737 | $6.24 | 63 |
| 2022 Q2 | 7,231,996 | $32,280,920 | -$8,047,771 | $4.46 | 61 |
| 2022 Q1 | 8,999,997 | $45,269,137 | +$8,091,446 | $5.03 | 72 |
| 2021 Q4 | 7,241,315 | $62,973,380 | -$7,065,660 | $8.71 | 72 |
| 2021 Q3 | 7,785,907 | $72,596,741 | -$2,908,464 | $9.33 | 65 |
| 2021 Q2 | 7,669,356 | $98,321,566 | +$70,526,213 | $12.82 | 66 |
| 2021 Q1 | 2,343,772 | $21,986,514 | +$21,240,741 | $9.20 | 46 |
| 2020 Q4 | 1,660 | $19,000 | +$14,000 | $11.70 | 2 |
| 2020 Q3 | 410 | $5,000 | $12.20 | 1 | |
| 2020 Q2 | 410 | $5,000 | $12.20 | 1 |